Vaidya saadhana: Ideal treatment – The elixir of wellness and recovery

In the contemporary era of rapid global development, the emergence of new diseases parallels the pace of progress. Advances in scientific research have enabled the development of treatments for each newly identified condition; however, the efficacy and long-term value of these interventions remain critical considerations. Western medical approaches often prioritize addressing immediate symptoms while overlooking potential future consequences. In some instances, a treatment may resolve one ailment only to precipitate additional or secondary health issues that often pose significant health challenges. Focusing solely on addressing the primary disease while neglecting secondary complications does not constitute an optimal therapeutic strategy. To achieve an ideal treatment outcome, concerted efforts must be directed toward managing both primary and secondary conditions, particularly in the context of serious or complex diseases. In contrast, Ayurvedic principles extend beyond merely treating a disease, emphasizing an ideal therapeutic framework that targets health as a whole, while aiming to restore equilibrium.1 Ayurvedic principles prioritize the development of treatments that are not only efficacious, fostering overall well-being. A therapy that alleviates one disease condition but provokes another disease is not Shuddha (~ideal). The ideal therapy (Shuddha chikitsa) is that which pacifies a disease without provoking any other disease. The verse goes like: प्रयोगः शमयेद्व्याधिं योऽन्यमन्यमुदीरयेत् | नासौ विशुद्धः, शुद्धस्तु शमयेद्यो न कोपयेत् || अन्वयः - यः प्रयोगः व्याधिं शमयेत्, अन्यम् अन्यम् उदीरयेत्, असौ विशुद्धः (प्रयोगः) न (अस्ति यः (व्याधिम्) शमयेत् (व्याधिम्) न कोपयेत्, सः (प्रयोगः) तु शुद्धः (अस्ति) ॥ It has been said that a treatment which cures one disease but causes other diseases is not an ideal treatment. A truly ideal treatment cures the disease without producing any new ailments.1 FRESH INSIGHTS Despite patients seeking timely care and personalized treatment approaches, nano medical system can completely address all conditions without risking adverse effects. The history of Pharmaceuticals, spanning over 120 years (1903–2024), reveals a pattern of innovation followed by unintended consequences, underscoring the need for vigilant oversight and holistic care. Early drugs like barbiturates (1903–1912)2 and sulfonamides (1935)3 tackled insomnia, seizures, and infections but introduced risks of addiction, toxicity, and organ damage.4 The thalidomide crisis (1957–1961), causing severe birth defects, led to the 1962 Kefauver-Harris Amendments, mandating rigorous safety testing.5 Later Selective Serotonin Reuptake Inhibitor (SSRIs) (1988), Vioxx (1999), and the opioid epidemic (1990s–2000s) prompted enhanced Post-Market Surveillance (PMS) and transparency due to risks like suicidal ideation, cardiovascular events, and addiction.6 Recent Coronavirus Disease 2019 vaccines (2020–2024) demonstrated advanced pharmacovigilance, identifying rare but serious Adverse Events (AEs), such as Myocarditis and Pericarditis in young males after mRNA doses and neurological complications like Cerebral Venous Sinus Thrombosis (CVST) and Ischemic stroke, emphasizing the need for real-time monitoring, especially in vulnerable groups.7,8 Pharmaceutical risks extend beyond historical crises to include ongoing challenges such as drug interactions, long-term side effects, manufacturing quality issues, and the potential for AEs that may not be detected during initial clinical trials. Drugs such as nimesulide, furazolidone, and phenylpropanolamine, banned by the United States Food and Drug Administration (US-FDA) due to nephrotoxic, hepatotoxic, and neurotoxic effects, highlight the importance of scrutinizing treatments to prioritize safety.9 Treatment complications also impose significant health and economic burdens.10 For instance, sepsis and pneumonia in patients with hematologic malignancies increase hospital costs.11 Furthermore, hemodialysis patients face debilitating symptoms such as fatigue (82%), intradialytic hypotension (76%), cramping (76%), dizziness (63%), headache (54%), pruritus (52%), and back pain (51%) ultimately compromising Quality of Life (QoL) and straining resources.12 Aggressive interventions carry further risks. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) study showed intensive glycemic control increased hypoglycaemia, weight gain, and mortality,13 while long-term corticosteroid use for conditions such as Rheumatoid Arthritis (RA) or Psoriasis causes Hypertension (30%), Bone fractures (21%–30%), Cataracts (1%–3%), Gastrointestinal issues (1%–5%), and a fourfold increased risk of Type II Diabetes due to metabolic complications.14,15 As discussed, short-term, symptom-focused treatments often lead to broader complications, transforming single conditions into complex syndromes. Historical and modern evidence highlight the limitations of conventional medicine, which, despite advancements, struggles with AEs and economic burdens, necessitating treatment methods fine-tuned to align with patients’ preferences, especially in emergency or life-saving situations, to ensure an optimal care experience. Shortcomings of contemporary disease management strategies are compiled in Figure 1.Figure 1: Gaps in contemporary disease managementAYURVEDA PERSPECTIVE Addressing a disease without confronting its underlying cause often results in superficial management, leading to the recurrence of symptoms or the emergence of complications, both of which affect a patient’s QoL. By prioritizing dietary and lifestyle adjustments, Ayurveda enhances digestion, boosts immunity, and promotes overall vitality, offering a holistic contrast to the often-standardized methods of conventional medicine. Ayurveda employs Herbal, Polyherbal, and Herbo-mineral remedies customized to the ailment for moderate conditions. In chronic cases, Panchakarma, a cornerstone of Ayurvedic therapy utilizes detoxification techniques such as therapeutic vomiting, purgation, enema, nasal instillation, and blood purification to eliminate toxins, which rebalance the body’s Doshas (~regulatory functional factors), and restore normal physiological functions. Additionally, Ayurveda advocates seasonal purification practices (~Ritucharya) to sustain optimal health. The Shatkriya kala (~six stages of disease progression) framework, which maps the stages of disease progression, provides a structured understanding that helps interrupt pathological processes and prevent complications.16 In modern times, the integration of these preventive strategies has significantly broadened, reinforcing Ayurveda’s relevance in contemporary healthcare. NOTABLE SUCCESS CASES Western medicine, widely recognized as the cornerstone of Healthcare, relies on a robust scientific foundation, systematic methodology, and therapies designed for widespread use across defined populations. Nevertheless, its focus on “fit and fix” often overlooks the long-term consequences of current interventions, revealing a key limitation. For example, Statins, widely used for cardiovascular prevention, show increased risks of Type II Diabetes, Muscle disorders (Myopathy), Liver dysfunction, Kidney issues, Cataracts, and Psychiatric complications with long-term use. A 2024 review confirmed Statin-Associated Symptoms (SAS), noting pleiotropic benefits but persistent harms such as Hemorrhagic strokes. Mendelian randomisation analyses from 2024 also link common drugs, including statins, to long-term brain structure changes and psychiatric disorders.17 In contrast, Ayurveda offers a promising alternative but is not without its own challenges, and blending it with Western medicine presents complexities that may only emerge as therapeutic approaches advance. Encouragingly, a 2024 systematic review advocates herbal interventions for Cardio-Vascular Disorder (CVD) management, highlighting their role in reducing reliance on pharmaceuticals associated with chronic AEs. Similarly, Maharishi Ayurveda multimodality (Diet, Herbs, and Meditation) reverses carotid intima-media thickness, a CVD surrogate, in high-risk patients.18 Extending this integrative perspective, a November 2025 integrative analysis correlates Tamaka shwasa pathophysiology with asthma’s inflammation, showing Ayurveda’s multimodal approach yields sustained remission, fewer exacerbations, and improved lung function versus pharmacotherapy alone. Moreover, Conference report from Advances in Integrative Medicine-Ancient Inspiration, Modern Evidence 2025 emphasize ongoing Randomized Controlled Trials (RCTs) validating these synergies in metabolic and respiratory disorders. This model bridges Dosha correction with modern biomarkers for safer, long-term control.19 Collectively, these examples illustrate how judiciously integrating Traditional and Western strategies can address complex treatment challenges. Ultimately, by seamlessly blending Ayurveda’s individualized, holistic framework with the precision of Western medical science, a revolutionary healthcare paradigm emerges. Through addressing both primary and secondary conditions while minimizing AEs, Ayurveda effectively complements conventional treatments, thereby promoting sustained well-being. As a treatment should not merely focus on short term satisfaction or temporary subsidence, rather it should focus on sustainability of “Cure without any Adverse Effect.” Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.